Riskpilot← Back to searchSign inGet full accessDUNE MEDICARE ApS
APSBankruptCVR 33377541Langelinie Allé 17Manufacture of pharmaceutical preparations · NACE 2120Est. 20108 employees
Revenue 2023
DKK -1,6M
+39% vs 2022
EBITDA margin
120.7%
-68% vs 2022
Equity ratio
-3071.1%
Financial strength
Net profit 2023
DKK -4,2M
-116% vs 2022
| Revenue | DKK -1,6M | +39% |
| EBITDA | DKK -2M | -68% |
| Net profit | DKK -4,2M | -116% |
| Total assets | DKK 546K | -88% |
| Equity | DKK -16,8M | -33% |
| Employees | 8 | — |
Legal name
DUNE MEDICARE ApS
CVR number
33377541
Legal form
Anpartsselskab
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
15. december 2010
Share capital
DKK 80.000
Employees
8 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Company purpose
Selskabets formål er at varetage udvikling, produktion og handel med alle former for medicin og farmaceutiske produkter samt aktiviteter i relation hermed, herunder sponsorering af foranstående aktiviteter.
Address
Langelinie Allé 17
Email
accounting@dunemedicare.com
- Event
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -1.154 | -1.881 | -1.611 | -1.529 | -1.233 | -1.348 | -1.640 | -3.064 | -1.472 | -3.918 | -1.181 | -1.645 |
| Staff expenses | -19 | -881 | -845 | -899 | -895 | -892 | -811 | -19 | -120 | -2 | -0 | -0 |
| EBITDA | -1.174 | -2.763 | -2.456 | -2.428 | -2.128 | -2.240 | -1.968 | -3.083 | -2.222 | -3.920 | -1.181 | -1.985 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -3 | -5 | -5 | -1 | -5 | -7 | -7 |
| EBIT | -1.174 | -2.763 | -2.456 | -2.428 | -2.128 | -2.243 | -1.973 | -3.087 | -2.223 | -3.925 | -1.188 | -1.992 |
| Net financials | 0 | 1 | -337 | -404 | -641 | -1.748 | -2.247 | -2.933 | -3.695 | -4.789 | 27.786 | -2.193 |
| Profit before tax | -1.173 | -2.762 | -2.793 | -2.831 | -2.769 | -3.991 | -4.220 | -6.020 | -5.918 | -8.714 | 26.598 | -4.186 |
| Tax | -0 | -293 | -690 | -608 | -570 | -462 | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | -1.173 | -2.469 | -2.103 | -2.223 | -2.198 | -3.529 | -4.220 | -6.020 | -5.918 | -8.714 | 26.598 | -4.186 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 751 | 1.113 | 1.400 | 1.719 | 2.663 | 1.867 | 2.438 | 2.276 | 3.945 | 3.726 | 4.380 | 546 |
| Equity | -1.798 | -4.267 | -6.370 | -8.593 | -10.792 | -14.320 | -18.540 | -24.560 | -30.478 | -39.193 | -12.594 | -16.780 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14.883 | 14.883 |
| Short-term debt | 2.549 | 5.380 | 7.770 | 10.312 | 13.454 | 16.187 | 20.978 | 26.836 | 34.423 | 42.919 | 2.092 | 2.444 |
| Total debt | 2.549 | 5.380 | 7.770 | 10.312 | 13.454 | 16.187 | 20.978 | 26.836 | 34.423 | 42.919 | 16.974 | 17.326 |
EBITDA margin
-198504200.0%
This company
15.8%
Market median
-1256355796% vs market
20122023
Equity ratio
-3071.1%
This company
38.2%
Market median
-8140% vs market
20122023
Return on equity
-418570200.0%
This company
18.4%
Market median
-2274838143% vs market
20122023
Net profit margin
-418570200.0%
This company
8.1%
Market median
-5167533433% vs market
20122023
Asset turnover
-3.01×
This company
1.12×
Market median
-369% vs market
20122023
Debt / equity
1.03×
This company
0.62×
Market median
-66% vs market
20122023
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JS Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
JS Chief Executive Officer | Chief Executive Officer | 2010 | — | — |
EH Chief Executive Officer | Chief Executive Officer | 2010 | — | — |
AH Unofficial title | Unofficial title | 2024 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DUNE MEDICARE ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jacob Sporon-Fiedler | Chief Executive Officer | 0 companies |
| Jacob Sporon-Fiedler | Chief Executive Officer | 0 companies |
| Elise Hellesø Rinvar | Chief Executive Officer | 0 companies |
| Anders Hoffmann Kønigsfeldt | Unofficial title | 0 companies |